Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
British Journal of Cancer|March 16, 2025
ctDNA variations according to treatment intensity in first-line metastatic colorectal cancerAdrien Grancher, Ludivine Beaussire-Trouvay, Virginie Vernon, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 9, 2024
Relative dose intensity of first-line triplet chemotherapy in metastatic colorectal cancerJulien Hoba, Adrien Grancher, Vincent Hautefeuille, et al.International Journal of Cancer|July 5, 2023
Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective multicenter studyPauline Marolleau, David Tougeron, Benoit Allignet, et al.British Journal of Cancer|August 4, 2017
Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumoursDavid Sefrioui, France Blanchard, Emmanuel Toure, et al.International Journal of Molecular Sciences|April 23, 2022
Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal CancersCamille Evrard, Stéphane Messina, David Sefrioui, et al.Journal of the National Cancer Institute|February 4, 2016
Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO StudyDavid Tougeron, Guillaume Mouillet, Isabelle Trouilloud, et al.International Journal of Cancer|January 24, 2020
Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: An AGEO retrospective multicenter studyDavid Tougeron, Benjamin Sueur, Aziz Zaanan, et al.International Journal of Cancer|December 23, 2016
Copy number variations in DCC/18q and ERBB2/17q are associated with disease-free survival in microsatellite stable colon cancerDavid Sefrioui, Thomas Vermeulin, France Blanchard, et al.Cardiovascular and Interventional Radiology|November 19, 2021
Evaluating the Effectiveness of Yttrium-90 Glass Microspheres in the Treatment of Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, and Metastatic Colorectal Cancer in Practice: Protocol for the Prospective PROACTIF Phase IV Registry Study in FranceEtienne Garin, Jean-Baptiste Pinaquy, Clement Bailly, et al.Oncotarget|November 2, 2016
Kinetics, prognostic and predictive values of ESR1 circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitorFlorian Clatot, Anne Perdrix, Laetitia Augusto, et al.Pageof 5